Debating the Food Debate, Two Views (1)

Several points in Kate Devine's article, "GM Food Debate Gets Spicy,"1 deserve amplification. The first pertains to the widespread recall of foods containing "StarLink" corn. The bottom line is that not a single person is at all likely to be harmed by this product, which differs from other commercial varieties by the presence of a Bacillus thuringiensis protein called Cry9C. The foods in question are actually far less likely than thousands of other products on the market to cause allergic or oth

Written byHenry Miller
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Several points in Kate Devine's article, "GM Food Debate Gets Spicy,"1 deserve amplification. The first pertains to the widespread recall of foods containing "StarLink" corn. The bottom line is that not a single person is at all likely to be harmed by this product, which differs from other commercial varieties by the presence of a Bacillus thuringiensis protein called Cry9C. The foods in question are actually far less likely than thousands of other products on the market to cause allergic or other health problems. For example, fava beans, a fixture of upscale restaurant cuisine in the United States and Europe, can be life-threatening to persons with hereditary glucose-6-phosphate dehydrogenase deficiency; by contrast, even after exhaustive testing, no allergic reactions, toxicity, or any other problem has been demonstrated with Cry9C or any substance similar to it.

The real problem lies not in StarLink corn, but in the United States' regulatory policy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies